Partnership-Humanwell Healthcare (Group) Co.-Humanwell Healthcare (Group) Co.-hth·华体

hth·华体(中国区)官方网站

Partnership

CURRENT LOCATION: HOME > Partnership

Partnership

We Seek

Anesthesia, including pain management, critical care (ICU) Men and women’s health, hormonal drugs CNS focus psychiatric, epilepsy, Parkinson, CVD Dermatology Respiratory focus asthma, COPD, IPF Oncology, including cancer supportive care

For the abovementioned areas, we are seeking to extend our pipeline and product portfolio by acquiring, in-licensing, or distribution products for the Chinese market:

Innovative pharmaceuticals Late-stage clinical projects (phase II or III) Pharmaceuticals with new application forms Established branded pharmaceuticals

We Offer

As a leading, fully-integrated Chinese pharmaceutical company with success stories for partnering cases, we can offer our partners:

Solid Chinese distribution network with more than 6000 sales/marketing professionals and close networking with key opinion leaders. Strong regulatory know-how and proven excellence when working with Chinese health authorities. Broad experience in performing clinical trials CMO/CDMO services with FDA/EMA standards

HUMANWELL HEALTHCARE (GROUP)CO.,LTD.

Add: No.666 Gaoxin Road, Wuhan, China

Pc: 430075

Tel: 86-27-87618263

Email: bd@renfu.com.cn

Stock Code: 600079.SH